Complete Filing Data
GOLUB CAPITAL BDC, Inc. reported Investment Company Dividend Distribution of $361.78 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean GOLUB CAPITAL BDC, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | $376.6M | $273.8M | $258.6M | $153.4M | $340.3M | $54.9M |
| General And Administrative Expense | $1.9M | $1.5M | $1.5M | $1.7M | $1.4M | $1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | $65.2M | $90.1M | $79.0M | $111.3M | $9.3M | $93.6M | $75.8M | $73.0M | $58.5M | $25.6M | $15.4M | $66.9M | $63.1M |
| General And Administrative Expense | $398.0K | $475.0K | $408.0K | $561.0K | $370.0K | $384.0K | $381.0K | $327.0K | $317.0K | $313.0K | $472.0K | $400.0K | $342.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $2.55B | $2.54B | $2.58B | $2.40B | $2.22B | $968.9M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $140.2M | $180.6M | $244.3M | $184.4M | $84.2M | |||
| Stockholders Equity Period Increase Decrease | -$32.0M | $1.47B | $3.4M | -$38.2M | $186.5M | $173.3M | ||
| Repayments Of Long Term Debt | $4.51B | $2.69B | $627.1M | $741.2M | $2.82B | $1.26B | ||
| Dividends Payable Current And Noncurrent | $439.1M | $373.0M | $238.4M | $204.8M | $194.9M | $202.2M | ||
| Debt And Equity Securities Unrealized Gain Loss | $50.6M | -$32.0M | $14.3M | -$56.8M | $161.9M | -$61.9M | ||
| Debt And Equity Securities Realized Gain Loss | -$72.2M | -$81.6M | -$46.5M | $18.9M | $13.0M | -$18.7M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$245.2M | $219.7M | -$40.2M | -$63.3M | $60.8M | $99.9M | ||
| Accretion Amortization Of Discounts And Premiums Investments | $8.9M | $10.4M | $12.9M | $9.0M | -$9.4M | -$23.5M | ||
| Accretion Amortization Of Discounts And Premiums Debt Securities | -$3.3M | -$2.1M | -$424.0K | -$1.7M | -$2.1M | -$1.4M | ||
| Retained Earnings Accumulated Deficit | -$153.0M | -$99.2M | -$132.3M | -$81.7M | ||||
| Cash Held In Foreign Currency Acquisition Cost | $8.0M | $4.5M | $7.0M | $5.1M | ||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Other Assets | $1.7M | $3.7M | $1.2M | $278.0K | ||||
| Money Market Funds Percent Of Net Assets | $0.05 | $0.03 | $0.02 | $0.02 | ||||
| Management And Incentive Fee Payable | $33.6M | $35.3M | $33.4M | $12.2M | ||||
| Long Term Debt | $4.60B | $3.12B | $3.08B | $2.55B | ||||
| Liabilities And Stockholders Equity | $8.70B | $5.73B | $5.68B | $5.16B | ||||
| Liabilities | $4.69B | $3.19B | $3.14B | $2.58B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $3.91B | $3.98B | $4.00B | $4.04B | $4.02B | $4.01B | $4.05B | $2.59B | $2.56B | $2.52B | $2.51B | $2.51B | $2.59B | $2.62B | $2.61B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $160.5M | $112.4M | $178.8M | $246.4M | $220.9M | $359.6M | $464.7M | $460.3M | $173.4M | $171.0M | $137.7M | $166.0M | $121.2M | $174.3M | $301.5M |
| Stockholders Equity Period Increase Decrease | -$73.4M | -$48.2M | $26.0M | $3.0M | $1.46B | $29.7M | $16.0M | $9.8M | -$7.5M | -$30.8M | -$35.9M | $16.1M | $24.8M | ||
| Repayments Of Long Term Debt | $190.2M | $3.04B | $629.5M | $88.0M | $336.8M | ||||||||||
| Dividends Payable Current And Noncurrent | $102.8M | $335.2M | $231.3M | $126.9M | $243.5M | $153.1M | $74.6M | $168.9M | $112.8M | $56.4M | $153.5M | $102.3M | $51.0M | ||
| Debt And Equity Securities Unrealized Gain Loss | -$29.0M | $43.6M | -$9.3M | -$41.1M | $4.8M | ||||||||||
| Debt And Equity Securities Realized Gain Loss | -$2.7M | -$25.4M | $909.0K | $4.0M | $14.6M | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $48.0M | -$136.6M | $32.8M | -$14.6M | $57.2M | ||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $3.4M | $569.0K | $3.7M | $3.9M | $640.0K | ||||||||||
| Accretion Amortization Of Discounts And Premiums Debt Securities | $285.0K | -$863.0K | -$41.0K | -$421.0K | -$467.0K | ||||||||||
| Retained Earnings Accumulated Deficit | -$86.3M | -$48.8M | -$207.9M | -$194.0M | -$168.5M | -$164.1M | -$83.0M | -$98.1M | -$144.1M | -$161.1M | -$163.2M | ||||
| Cash Held In Foreign Currency Acquisition Cost | $9.4M | $11.7M | $5.9M | $6.6M | $7.0M | ||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Other Assets | $4.3M | $9.0M | $9.9M | $4.9M | $16.9M | $20.1M | $3.4M | $19.3M | $848.0K | $1.0M | $1.1M | ||||
| Money Market Funds Percent Of Net Assets | $0.02 | $0.02 | $0.03 | $0.05 | $0.04 | $0.09 | $0.17 | $0.05 | $0.03 | $0.03 | $0.02 | ||||
| Management And Incentive Fee Payable | $39.6M | $40.9M | $40.6M | $40.9M | $38.8M | $14.3M | $29.2M | $35.2M | $37.9M | $36.7M | $35.1M | ||||
| Long Term Debt | $4.88B | $4.90B | $5.13B | $4.81B | $4.89B | $4.32B | $3.27B | $3.07B | $3.15B | $3.10B | $3.08B | ||||
| Liabilities And Stockholders Equity | $8.89B | $8.98B | $9.24B | $8.95B | $9.01B | $8.48B | $5.94B | $5.70B | $5.74B | $5.67B | $5.67B | ||||
| Liabilities | $4.98B | $5.00B | $5.24B | $4.91B | $4.99B | $4.42B | $3.35B | $3.14B | $3.22B | $3.17B | $3.15B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Proceeds From Purchases For Undrawn Portion Of Revolving Loans Operating Activities | -$6.3M | -$2.6M | -$381.0K | -$1.8M | $12.2M | -$9.2M |
| Proceeds From Issuance Of Long Term Debt | $4.80B | $2.93B | $652.6M | $1.29B | $3.36B | $1.05B |
| Proceeds From Disposition Of Investment Operating Activity | $1.52B | $1.26B | $670.2M | $1.26B | $1.59B | $706.0M |
| Proceeds From Derivative Instrument Operating Activities | $6.2M | $7.9M | $2.7M | $1.1M | $0.00 | $0.00 |
| Payments Of Dividends Common Stock | $368.2M | $338.2M | $191.5M | $155.2M | $139.1M | $136.4M |
| Payments Of Debt Issuance Costs | $10.6M | $19.0M | $5.8M | $6.7M | $22.2M | $4.5M |
| Payments For Purchase Of Investment Operating Activity | $1.95B | $1.30B | $675.3M | $1.88B | $2.08B | $643.2M |
| Net Cash Provided By Used In Operating Activities | -$113.6M | $343.9M | $195.4M | -$416.5M | -$306.0M | $187.7M |
| Net Cash Provided By Used In Financing Activities | -$131.6M | -$124.2M | -$235.5M | $353.1M | $366.9M | -$87.8M |
| Increase Decrease In Other Operating Assets | $3.1M | $4.7M | $2.5M | $910.0K | -$524.0K | $450.0K |
| Increase Decrease In Interest Payable Net | -$7.4M | $8.3M | $4.4M | $7.9M | $4.6M | -$5.8M |
| Increase Decrease In Accrued Trustee Fees | $861.0K | -$161.0K | $106.0K | $225.0K | $0.00 | -$207.0K |
| Increase Decrease In Accrued Interest Receivable Net | -$6.0M | -$16.2M | $37.3M | $2.5M | $998.0K | $3.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$540.0K | -$1.3M | $1.2M | $505.0K | $1.8M | -$22.5M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$1.9M | -$331.0K | -$171.0K | -$458.0K | -$889.0K | $346.0K |
| Payments For Repurchase Of Common Stock | $40.6M | $4.8M | $16.9M | $0.00 | $0.00 | $45.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q4 2024 | Q4 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|
| Proceeds From Purchases For Undrawn Portion Of Revolving Loans Operating Activities | -$3.4M | -$2.2M | -$235.0K | -$868.0K | -$336.0K |
| Proceeds From Issuance Of Long Term Debt | $165.3M | $3.39B | $563.7M | $77.1M | $620.2M |
| Proceeds From Disposition Of Investment Operating Activity | $302.9M | $450.2M | $179.4M | $253.8M | $661.8M |
| Proceeds From Derivative Instrument Operating Activities | $0.00 | $4.1M | $0.00 | $463.0K | $0.00 |
| Payments Of Dividends Common Stock | $84.5M | $108.3M | $59.7M | $47.2M | $38.3M |
| Payments Of Debt Issuance Costs | $451.0K | $6.0M | $5.3M | $178.0K | $6.2M |
| Payments For Purchase Of Investment Operating Activity | $172.7M | $909.5M | $73.2M | $248.9M | $890.9M |
| Net Cash Provided By Used In Operating Activities | $212.0M | -$374.7M | $163.6M | $52.9M | -$181.7M |
| Net Cash Provided By Used In Financing Activities | -$164.0M | $238.1M | -$130.8M | -$67.5M | $238.9M |
| Increase Decrease In Other Operating Assets | -$4.8M | $11.6M | $12.4M | -$98.0K | $294.0K |
| Increase Decrease In Interest Payable Net | $10.8M | $5.8M | $1.8M | $4.6M | $3.7M |
| Increase Decrease In Accrued Trustee Fees | -$434.0K | -$55.0K | -$100.0K | -$199.0K | $0.00 |
| Increase Decrease In Accrued Interest Receivable Net | $4.1M | -$740.0K | -$3.6M | $7.5M | $3.0M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.3M | -$3.0M | $1.1M | $1.3M | -$241.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $125.0K | -$2.1M | $396.0K | $56.0K | -$25.0K |
| Payments For Repurchase Of Common Stock | $35.9M | $0.00 | $9.2M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $15.00 | $15.32 | $15.03 | $14.71 | $15.26 | $14.33 | $16.76 | $16.10 | $16.08 |
| Common Stock Shares Outstanding | 264.3M | 169.6M | 170.9M | 170.0M | 167.3M | 132.7M | 60.2M | ||
| Weighted Average Number Of Shares Outstanding Basic | 266.0M | 201.3M | 170.3M | 170.7M | 168.0M | 148.9M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 266.0M | 201.3M | 170.3M | 170.7M | 168.0M | 148.9M | |||
| Earnings Per Share Diluted | $1.42 | $1.36 | $1.52 | $0.90 | $2.03 | $0.37 | |||
| Earnings Per Share Basic | $1.42 | $1.36 | $1.52 | $0.90 | $2.03 | $0.37 | |||
| Common Stock Dividends Per Share Declared | $1.65 | $1.89 | $1.40 | $1.20 | $1.16 | $1.37 | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | ||||||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Authorized | 350.0M | 350.0M | 350.0M | 200.0M | |||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $14.84 | $14.97 | $15.13 | $15.19 | ||||||||||||
| Common Stock Shares Outstanding | 263.4M | 266.0M | 266.4M | 268.8M | 265.5M | 264.6M | 171.5M | 170.6M | 169.6M | 170.1M | 170.9M | 170.9M | 170.9M | 170.9M | ||
| Weighted Average Number Of Shares Outstanding Basic | 263.7M | 266.8M | 266.5M | 264.3M | 200.0M | 170.6M | 169.7M | 170.0M | 170.8M | 170.9M | 170.9M | 170.9M | 170.0M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 263.7M | 266.8M | 266.5M | 264.3M | 200.0M | 170.6M | 169.7M | 170.0M | 170.8M | 170.9M | 170.9M | 170.9M | 170.0M | |||
| Earnings Per Share Diluted | $0.25 | $0.34 | $0.30 | $0.42 | $0.05 | $0.55 | $0.45 | $0.43 | $0.34 | $0.15 | $0.09 | $0.39 | $0.37 | |||
| Earnings Per Share Basic | $0.25 | $0.34 | $0.30 | $0.42 | $0.05 | $0.55 | $0.45 | $0.43 | $0.34 | $0.15 | $0.09 | $0.39 | $0.37 | |||
| Common Stock Dividends Per Share Declared | $0.39 | $0.39 | $0.39 | $0.48 | $0.50 | $0.46 | $0.44 | $0.33 | $0.33 | $0.33 | $0.30 | $0.30 | $0.30 | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | |||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Investment Company Dividend Distribution | $361.8M | $373.0M | $238.4M | $40.2M | $38.3M | $33.8M | $40.8M |
| Stock Repurchased During Period Value | $40.6M | $4.8M | $16.9M | ||||
| Stock Repurchased During Period Shares | 2.9M | 9.4K | 1.3M | ||||
| Stock Issued During Period Shares Dividend Reinvestment Plan | 0.00 | 0.00 | 837.2K | 0.00 | 1.1M | ||
| Unrealized Gain Loss Investment And Derivative Operating Tax Expense Benefit | -$563.0K | -$620.0K | -$308.0K | $855.0K | $543.0K | $0.00 | |
| Professional Fees | $8.0M | $5.5M | $5.0M | $3.6M | $4.0M | $4.7M | |
| Net Investment Income | $396.8M | $383.6M | $292.8M | $196.2M | $167.7M | $139.1M | |
| Management Fee Expense | $87.9M | $62.5M | $70.8M | $73.9M | $61.9M | $59.2M | |
| Investment Income Operating After Expense And Tax | $397.3M | $382.4M | $289.1M | $196.1M | $167.7M | $139.1M | |
| Investment Income Investment Expense | $474.0M | $368.4M | $310.3M | $193.5M | $143.5M | $159.9M | |
| Interest Income Operating Paid In Kind | $52.3M | $49.7M | $40.6M | $23.4M | $13.9M | $11.0M | |
| Gross Investment Income Operating | $870.8M | $724.7M | $603.1M | $387.8M | $307.1M | $299.0M | |
| Gain Loss On Sale Of Derivatives | $4.2M | $3.6M | $2.7M | $1.1M | $0.00 | $0.00 | |
| Foreign Currency Transaction Gain Loss Unrealized | $9.2M | $21.7M | $16.7M | -$37.3M | $2.2M | -$2.7M | |
| Foreign Currency Transaction Gain Loss Realized | -$4.3M | -$2.0M | -$328.0K | $371.0K | -$5.1M | $20.0K | |
| Amortization Of Financing Costs | $10.0M | $9.2M | $7.4M | $7.3M | $10.2M | $3.5M | |
| Administrative Fees Expense | $12.3M | $9.3M | $8.3M | $7.2M | $7.2M | $6.0M | |
| Stock Issued During Period Value Dividend Reinvestment Plan | $33.7M | $44.3M | $11.0M | $13.2M | $14.7M | $20.2M | |
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | $51.2M | -$29.4M | $13.6M | -$61.9M | $165.2M | ||
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$72.4M | -$79.9M | -$44.1M | $20.4M | $7.9M | ||
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$21.1M | -$109.3M | -$30.6M | -$41.5M | $173.2M | ||
| Investment Income Operating Tax Expense Benefit | -$475.0K | $1.2M | $3.7M | $72.0K | $0.00 | $0.00 | |
| Interest Income Operating Paid In Kind Capitalized | $55.4M | $52.6M | $38.8M | $21.5M | $16.1M | ||
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $474.0M | $341.0M | $310.3M | $191.6M | $139.5M | $159.9M | |
| Incentive Fee Expense Net Of Adjustments | $73.3M | $77.2M | $74.1M | $17.8M | $3.2M | ||
| Investment Company Contractual Fee Waived | $27.3M | $0.00 | $0.00 | $4.0M | $0.00 | ||
| Realized Gain Loss Investment And Derivative Operating Tax Expense Benefit | $0.00 | $0.00 | $207.0K | $302.0K | $0.00 | $0.00 | |
| Interest Paid Net | $280.2M | $180.1M | $138.4M | $72.5M | $48.8M | $74.9M | |
| Stock Issued1 | $33.7M | $44.3M | $0.00 | $13.2M | $41.1M | $20.2M | |
| Money Market Funds At Carrying Value | $213.1M | $72.8M | $37.2M | $38.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Company Dividend Distribution | $102.8M | $103.9M | $104.5M | $126.9M | $90.4M | $78.5M | $74.6M | $56.1M | $56.4M | $47.2M | $51.3M | $51.3M | $51.0M | ||
| Stock Repurchased During Period Value | $35.9M | $34.3M | $1.1M | $7.1M | $9.6M | ||||||||||
| Stock Repurchased During Period Shares | 2.6M | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Stock Issued During Period Shares Dividend Reinvestment Plan | 100.6K | 797.4K | 152.3K | 0.00 | 0.00 | 0.00 | 837.2K | ||||||||
| Unrealized Gain Loss Investment And Derivative Operating Tax Expense Benefit | $0.00 | -$211.0K | -$146.0K | -$52.0K | -$190.0K | -$350.0K | $23.0K | -$78.0K | -$45.0K | -$453.0K | $478.0K | $97.0K | $495.0K | ||
| Professional Fees | $1.8M | $2.1M | $1.8M | $1.8M | $1.5M | $1.3M | $1.3M | $1.2M | $1.3M | $1.2M | $1.0M | $729.0K | $899.0K | ||
| Net Investment Income | $95.8M | $101.3M | $98.7M | $96.1M | $92.8M | $87.1M | $84.0M | $73.8M | $70.4M | $63.9M | $53.9M | $43.4M | $44.8M | ||
| Management Fee Expense | $22.1M | $22.1M | $21.7M | $21.6M | $14.4M | $13.7M | $14.0M | $19.0M | $18.7M | $19.1M | $19.0M | $18.0M | $17.5M | ||
| Investment Income Operating After Expense And Tax | $95.8M | $101.3M | $98.7M | $96.6M | $92.7M | $86.5M | $83.5M | $73.8M | $70.2M | $61.7M | $53.9M | $43.4M | $44.8M | ||
| Investment Income Investment Expense | $111.2M | $117.1M | $115.2M | $124.6M | $92.8M | $82.3M | $80.7M | $80.9M | $76.5M | $73.0M | $41.7M | $44.4M | $41.8M | ||
| Interest Income Operating Paid In Kind | $14.5M | $13.5M | $14.0M | $11.0M | $10.2M | $11.8M | $11.8M | $9.6M | $9.2M | $8.5M | $5.4M | $4.6M | $3.5M | ||
| Gross Investment Income Operating | $207.0M | $218.3M | $213.9M | $220.7M | $171.3M | $164.2M | $164.8M | $154.7M | $147.0M | $136.9M | $95.6M | $86.0M | $86.6M | ||
| Gain Loss On Sale Of Derivatives | $0.00 | $0.00 | $6.0M | $1.2M | $624.0K | $0.00 | $0.00 | $2.0M | $708.0K | $463.0K | $1.1M | $0.00 | $0.00 | ||
| Foreign Currency Transaction Gain Loss Unrealized | $2.0M | $23.9M | $11.4M | -$23.0M | $3.7M | -$10.2M | $6.2M | $3.4M | $2.6M | $15.9M | -$13.5M | -$4.7M | -$797.0K | ||
| Foreign Currency Transaction Gain Loss Realized | -$1.1M | -$400.0K | -$174.0K | -$3.7M | -$6.2M | $4.5M | $187.0K | $1.1M | $17.0K | -$1.2M | -$165.0K | $227.0K | -$25.0K | ||
| Amortization Of Financing Costs | $2.6M | $2.4M | $2.5M | $2.6M | $2.2M | $2.5M | $2.1M | $1.9M | $1.7M | $1.7M | $1.8M | $1.8M | $1.7M | ||
| Administrative Fees Expense | $3.2M | $3.1M | $3.2M | $2.9M | $2.1M | $2.1M | $2.2M | $2.0M | $2.0M | $2.2M | $2.0M | $1.6M | $1.8M | ||
| Stock Issued During Period Value Dividend Reinvestment Plan | $15.2M | $18.6M | $14.8M | $14.6M | $14.9M | $9.2M | $457.0K | $12.7M | |||||||
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$26.7M | -$11.4M | -$8.8M | $42.6M | -$45.9M | $20.5M | -$8.8M | $41.1M | -$7.0M | -$39.6M | -$40.6M | $23.2M | |||
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$3.8M | -$24.0K | -$11.0M | -$27.9M | -$37.7M | -$13.8M | $1.1M | -$41.9M | -$4.8M | $3.3M | $2.5M | $372.0K | |||
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$30.5M | -$11.4M | -$19.8M | $14.7M | -$83.7M | $6.7M | -$7.7M | -$873.0K | -$11.7M | -$36.3M | -$38.0M | $23.5M | |||
| Investment Income Operating Tax Expense Benefit | $0.00 | $0.00 | $0.00 | -$475.0K | $125.0K | $570.0K | $500.0K | $0.00 | $232.0K | $2.2M | $0.00 | $0.00 | $0.00 | ||
| Interest Income Operating Paid In Kind Capitalized | $14.2M | $12.5M | $14.7M | $13.2M | $11.2M | $9.7M | $13.7M | $10.4M | $9.5M | $7.8M | $6.1M | $5.1M | |||
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $117.1M | $115.2M | $78.4M | $77.1M | $80.9M | $76.5M | $41.7M | $42.5M | |||||||
| Incentive Fee Expense Net Of Adjustments | $17.5M | $18.5M | $18.2M | $18.1M | $14.4M | $20.6M | $21.3M | $18.9M | $18.0M | $16.0M | -$4.1M | ||||
| Investment Company Contractual Fee Waived | $0.00 | $0.00 | $14.4M | $5.2M | $0.00 | $0.00 | $0.00 | $1.9M | |||||||
| Realized Gain Loss Investment And Derivative Operating Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $207.0K | $0.00 | $0.00 | $0.00 | ||||||
| Interest Paid Net | $53.1M | $69.1M | $37.6M | $27.5M | $12.0M | ||||||||||
| Stock Issued1 | $0.00 | $18.6M | $14.9M | $0.00 | $12.7M | ||||||||||
| Money Market Funds At Carrying Value | $60.3M | $93.7M | $108.9M | $181.3M | $153.2M | $372.9M | $437.8M | $120.0M | $63.9M | $64.3M | $51.5M |
Most recent annual filing with the SEC: November 18, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.